Psoriatic Arthritis Secondary to Psoriasis (Service-Connected)

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Psoriatic Arthritis is a documented secondary pairing for Psoriasis (Service-Connected) with strong medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

The VA rates Psoriatic Arthritis separately under its own 38 CFR Part 4 diagnostic code, then combines it with Psoriasis (Service-Connected) and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

The medical evidence supporting Psoriatic Arthritis as secondary to Psoriasis (Service-Connected) is rated strong. Psoriatic arthritis (PsA) develops in 20-30% of psoriasis patients, driven by the same Th17-mediated inflammatory cascade that produces skin lesions. IL-17 and IL-23 overproduction in psoriasis does not remain skin-limited — these cytokines circulate systemically, activating synovial fibroblasts and osteoclasts in joints. The enthesis (tendon/ligament insertion into bone) is the primary target in PsA because it is a site of high mechanical stress where IL-23-responsive resident T cells become activated by inflammatory cytokines. Enthesitis progresses to synovitis, dactylitis, and eventually erosive joint disease affecting the DIP joints, sacroiliac joints, and spine. Nail psoriasis is a particularly strong predictor of PsA development because the nail matrix and DIP joint enthesis share a common anatomical compartment.

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.